Inflammatory Myofibroblastic Tumor of the Upper Airways Harboring a New TRAF3-ALK Fusion Transcript
Inflammatory myofibroblastic tumor (IMT) is a rare disease that mainly involves the lung and the abdomen with an intermediate clinical course but a recurrence rate between 15-30%. Radical surgery represents the gold standard of treatment, while chemotherapy and radiotherapy are considered for unrese...
Saved in:
Main Authors: | Valentina Di Ruscio (Author), Angela Mastronuzzi (Author), Ida Russo (Author), Marianna Neri (Author), Alessandra Stracuzzi (Author), Isabella Giovannoni (Author), Maria Luisa Tropiano (Author), Maria Antonietta De Ioris (Author), Giuseppe Maria Milano (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
by: Chrisann Kyi, et al.
Published: (2021) -
Placenta-associated uterine inflammatory myofibroblastic tumor with a novel FBLN1-ALK1 fusion
by: Jaclyn C. Watkins, et al.
Published: (2022) -
Gastric CLTC-ALK fusion-positive inflammatory myofibroblastic tumor showing an endoscopic superficial depressed-type appearance
by: Mai Nakanishi, MD, et al.
Published: (2019) -
ALK positive histiocytosis in an adult female with an EML4-ALK RNA fusion
by: Jay Mehta, et al.
Published: (2020) -
An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor
by: Sanjivini V. Jacob, et al.
Published: (2014)